CPVB COBRE Vision

Effective therapies for blood vessel diseases, based on mechanistic understanding.

CPVB COBRE Mission

This vision will be accomplished through research of a group of outstanding investigators who are using cutting edge tools to understand diseases of the blood vessels.

Strategy

Strengthening and broadening of the CardioPulmonary Vascular Biology (CPVB) COBRE will provide the basis for new scientific collaborations, better understanding of blood vessel diseases, and improved treatments.

Meet the Investigators

Principal/Junior Investigators

Sean Monaghan, MD
jessica-plavicki
Alan Morrison, MD, PhD
Yang Zhou, PhD
Hongwei Yao, PhD

Graduated Investigators

corey-ventetuolo
peng-zhang
Qing-Lu
ruhul-abid

Kudos

Jamila H Siamwala, PhD receives $310,000 for Neurovascular Aging Phenotypes of Alzheimer's Disease and Progeria project

Jamila Siamwala, PhD, Molecular Pharmacology, Physiology and Biotechnology (MPPB), received $310,000 in response to "NOT-AG-18-008 Alzheimer's Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimer's disease" announcement. Her project is titled "Neurovascular Aging Phenotypes of Alzheimer's Disease and Progeria: Focus on Inflammation and Blood Brain Barrier." Dr. Siamwala is a CPVB COBRE pilot project investigator. Her COBRE project is titled "Right Ventricular Fibrosis from PAH is Dependent on Macrophage IL-1b Signaling."

News

Funding Opportunities

CardioPulmonary Vascular Biology Center for Biomedical Research Excellence (COBRE)

Anticipated start date is June 1, 2019.
Faculty or senior post-doctoral fellows on the cusp of faculty appointment at a Rhode Island academic institution are eligible to apply.